Overview / Abstract: |
This educational activity will utilize a case study to discuss minimal residual disease measurement and treatment options for newly diagnosed multiple myeloma patients who are eligible for autologous stem cell transplant (ASCT). |
Expiration |
Sep 22, 2021 |
Discipline(s) |
Clinical Laboratory CE, Nursing CNE, Physician CME, Physician Assistant CME |
Format |
Monograph, Online |
Credits / Hours |
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Penn State College of Medicine, RedMedEd, and the Multiple Myeloma Research Foundation. Penn State College of Medicine is accredited by the ACCME to provide continuing medical education for physicians. Penn State College of Medicine designates this enduring material for 0.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Successful completion of this CME activity enables the participant to earn 0.25 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants who opt in will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to the ACCME for the purpose of granting ABIM MOC points. |
Accreditation |
ACCME, ABIM MOC points |
Is This Activity Certified for "Live" Credit? |
YES |
Presenters / Authors / Faculty |
Faith E. Davies, MBBCh, MD |
Activity Specialities / Related Topics |
Education / Teaching, Hematology, Oncology / Cancer / Radiation Therapy |
Sponsors / Supporters / Grant Providers |
Support for this activity has been provided through educational grants from Adaptive Biotechnologies; Amgen; Bristol Myers Squibb; Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC; Karyopharm Therapeutics; Oncopeptides; and Sanofi Genzyme. |
Keywords / Search Terms |
RedMedEd RedMedEd RedMedEd, MMRF, PSCM, multiple myeloma, MM, risk, case study, free, CME, oncology, high-risk, hematologist, oncologist, patients, myeloma, smoldering myeloma, smoldering, free, CME, CE Free CE CME Live CE CME Free CE CME Live CE CME |